Wordt geladen...
Biomarkers and Surrogate Markers: An FDA Perspective
Summary: Interest is increasing rapidly in the use of surrogate markers as primary measures of the effectiveness of investigational drugs in definitive drug trials. Many such surrogate markers have been proposed as potential candidates for use in definitive effectiveness trials of agents to treat ne...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The American Society for Experimental NeuroTherapeutics, Inc.
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC534924/ https://ncbi.nlm.nih.gov/pubmed/15717019 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|